NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20180009

Company第一三共制药（上海）有限公司

Registration Date

April 25, 2023

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Brand Name

思卫卡

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)。

Drug Type

化学药品

Registration Date

April 25, 2023

Company Information

Applicant Company

Company Name第一三共制药（上海）有限公司

Company Address

中国（上海）自由贸易试验区居里路500号

Manufacturing Company

Company Name第一三共制药（上海）有限公司

Company Address

上海市浦东新区张江高科技园区居里路500号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氨氯地平片 - NMPA 批准文号 | MedPath